Human Brucellosis
Conditions
Interventions
Intervention group:A new integrated management model based on the electronic monitors
Control group:Electronic monitors in the control group only recorded and uploaded patients' medication administration without any reminders from the electronic monitors. Moreover, there are no reminde
Sponsors
Chinese Center for Disease Control and Prevention
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients >=15 years old; 2. According to the diagnostic criteria Brucellosis Diagnosis (WS269-2019), the cases were determined to be laboratory-confirmed; 3. Will live in the pilot area in the next two years; 4. Agree to receive treatment in county-level cooperative medical institutions and accept treatment management by responsible personnel; 5. Patients have communication tools that can achieve daily contact, such as mobile phones and landlines
Exclusion criteria
Exclusion criteria: 1. Patients with communication disorders (including mental disorders, visual, hearing and language disorders); 2. Patients infected with the human immunodeficiency virus, or undergoing chemotherapy, or suffering from other diseases of the immune system, or severe cardiopulmonary insufficiency, or cirrhosis of the liver; 3. Patients at risk of serious complications; 4. Patients with previous experience in using electronic monitors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irregular medication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of patients with an irregular medication rate over 10%,;The percentage of weeks with over 2 days of irregular medication;The percentage of weeks with over 4 days of irregular medication;Cure rate of patients; | — |
Countries
China
Contacts
Public ContactChen Qiulan
Chinese Center for Disease Control and Prevention
Outcome results
None listed